Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)
Condition: COPD Interventions: Drug: Revefenacin 175 mcg in 3 ML Inhalation Solution; Drug: Placebo inhalation solution QD Sponsors: Mylan Inc.; Mylan Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials